The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Aromatase Inhibitors in the Treatment of Breast Cancer
Open accessAbstract
Estradiol, the most potent endogenous estrogen, is biosynthesized from androgens by the cytochrome P450 enzyme complex called aromatase. Aromatase is present in breast tissue, and intratumoral aromatase is the source of local estrogen production in breast cancer tissues. Inhibition of aromatase is an important approach for reducing growth-stimulatory effects of estrogens in estrogen-dependent breast cancer. Steroidal inhibitors that have been developed to date build upon the basic androstenedione nucleus and incorporate chemical substituents at varying positions on the steroid. Nonsteroidal aromatase inhibitors can be divided into three classes: aminoglutethimide-like molecules, imidazole/triazole derivatives, and flavonoid analogs. Mechanism-based aromatase inhibitors are steroidal inhibitors that mimic the substrate, are converted by the enzyme to a reactive intermediate, and result in the inactivation of aromatase. Both steroidal and nonsteroidal aromatase inhibitors have shown clinical efficacy in the treatment of breast cancer. The potent and selective third-generation aromatase inhibitors, anastrozole, letrozole, and exemestane, were introduced into the market as endocrine therapy in postmenopausal patients failing antiestrogen therapy alone or multiple hormonal therapies. These agents are currently approved as first-line therapy for the treatment of postmenopausal women with metastatic estrogen-dependent breast cancer. Several clinical studies of aromatase inhibitors are currently focusing on the use of these agents in the adjuvant setting for the treatment of early breast cancer. Use of an aromatase inhibitor as initial therapy or after treatment with tamoxifen is now recommended as adjuvant hormonal therapy for a postmenopausal woman with hormone-dependent breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes
Meunier, B., de Visser, S. P., & Shaik, S. (2004) · Chemical Reviews · doi:10.1021/cr020443g · Cited by 2,398
Goss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032312 · Cited by 1,795
Coombes, R. C., Hall, E., Gibson, L. J., Paridaens, R., Jassem, J., Delozier, T., Jones, S. E., Alvarez, I., Bertelli, G., Ortmann, O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040331 · Cited by 1,759
Aromatase Cytochrome P450, The Enzyme Responsible for Estrogen Biosynthesis*
SIMPSON, E. R., MAHENDROO, M. S., MEANS, G. D., KILGORE, M. W., HINSHELWOOD, M. M., GRAHAM-LORENCE, S., AMARNEH, B., ITO, Y., FISHER, C. R., MICHAEL, M. D., et al. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-342 · Cited by 1,537
Winer, E. P., Hudis, C., Burstein, H. J., Wolff, A. C., Pritchard, K. I., Ingle, J. N., Chlebowski, R. T., Gelber, R., Edge, S. B., Gralow, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.121 · Cited by 1,031
Mouridsen, H., Gershanovich, M., Sun, Y., Pérez-Carrión, R., Boni, C., Monnier, A., Apffelstaedt, J., Smith, R., Sleeboom, H. P., Jänicke, F., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.10.2596 · Cited by 1,015
Nabholtz, J. M., Buzdar, A., Pollak, M., Harwin, W., Burton, G., Mangalik, A., Steinberg, M., Webster, A., & von Euler, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.22.3758 · Cited by 992
The ATAC (Arimidex, T. A. O. I. C. T. G. (2003) · Cancer · doi:10.1002/cncr.11745 · Cited by 861
Bonneterre, J., Thürlimann, B., Robertson, J. F. R., Krzakowski, M., Mauriac, L., Koralewski, P., Vergote, I., Webster, A., Steinberg, M., & von Euler, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.22.3748 · Cited by 842
Simpson, E. R., Clyne, C., Rubin, G., Boon, W. C., Robertson, K., Britt, K., Speed, C., & Jones, M. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.081601.142703 · Cited by 773
Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450
Hodek, P., Trefil, P., & Stiborová, M. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(01)00285-x · Cited by 649
Dombernowsky, P., Smith, I., Falkson, G., Leonard, R., Panasci, L., Bellmunt, J., Bezwoda, W., Gardin, G., Gudgeon, A., Morgan, M., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.453 · Cited by 638
Geisler, J., Haynes, B., Anker, G., Dowsett, M., & Lønning, P. E. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.751 · Cited by 604
Bonneterre, J., Buzdar, A., Nabholtz, J.-M. A., Robertson, J. F. R., Th�rlimann, B., von Euler, M., Sahmoud, T., Webster, A., Steinberg, M., & Arimidex Writing Committee on behalf of the Investigators Committee Members (2001) · Cancer · doi:10.1002/1097-0142(20011101)92:9<2247::aid-cncr1570>3.0.co;2-y · Cited by 574
Phytoestrogens: epidemiology and a possible role in cancer protection.
Adlercreutz, H. (1995) · Environmental Health Perspectives · doi:10.1289/ehp.95103s7103 · Cited by 553
Zhao, Y. D., Agarwal, V. R., Mendelson, C. R., & Simpson, E. R. (1996) · Endocrinology · doi:10.1210/en.137.12.5739 · Cited by 434
Buzdar, A., Jonat, W., Howell, A., Jones, S. E., Blomqvist, C., Vogel, C. L., Eiermann, W., Wolter, J. M., Azab, M., Webster, A., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.7.2000 · Cited by 406
Endocrine treatment of breast cancer in women
SANTEN, R. J., MANNI, A., HARVEY, H., & REDMOND, C. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-2-221 · Cited by 399 · cited 1×
“Numerous clinical trials performed since the early 1980s have demonstrated the clinical efficacy of combination therapy of aminoglutethimide with corticosteroid replacement (96, 119) in treatment of hormonedependent breast cancer.”
Background(2008) · doi:10.1016/b978-1-4160-3703-3.x5001-7 · Cited by 373
Buzdar, A., Douma, J., Davidson, N., Elledge, R., Morgan, M., Smith, R., Porter, L., Nabholtz, J., Xiang, X., & Brady, C. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.14.3357 · Cited by 365
BRODIE, A. M. H., SCHWARZEL, W. C., SHAIKH, A. A., & BRODIE, H. J. (1977) · Endocrinology · doi:10.1210/endo-100-6-1684 · Cited by 365
Nonsteroidal Antiinflammatory Drugs and Breast Cancer
Harris, R. E., Namboodiri, K. K., & Farrar, W. B. (1996) · Epidemiology · doi:10.1097/00001648-199603000-00017 · Cited by 345
Kao, Y. C., Zhou, C., Sherman, M., Laughton, C. A., & Chen, S. (1998) · Environmental Health Perspectives · doi:10.1289/ehp.9810685 · Cited by 338
Geisler, J., King, N., Dowsett, M., Ottestad, L., Lundgren, S., Walton, P., Kormeset, P., & Lønning, P. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.531 · Cited by 336
Bulun, S. E., Price, T. M., Aitken, J., Mahendroo, M. S., & Simpson, E. R. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.6.8117355 · Cited by 335
Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes
Wang, C., Mäkelä, T., Hase, T., Adlercreutz, H., & Kurzer, M. S. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90030-2 · Cited by 322
Mechanism and inhibition of cytochrome P-450 aromatase
Cole, P. A., & Robinson, C. H. (1990) · Journal of Medicinal Chemistry · doi:10.1021/jm00173a001 · Cited by 319
Lønning, P. E., Bajetta, E., Murray, R., Tubiana-Hulin, M., Eisenberg, P. D., Mickiewicz, E., Celio, L., Pitt, P., Mita, M., Aaronson, N. K., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.11.2234 · Cited by 316
Geisler, J., King, N. C., Anker, G. B., Ornati, G., di Salle, E., Lønning, P. E., & Dowsett, M. (1998) · PubMed · Cited by 314
Inhibition of Human Estrogen Synthetase (Aromatase) by Flavones
Kellis, J. T., & Vickery, L. E. (1984) · Science · doi:10.1126/science.6474163 · Cited by 309
SCHWARZEL, W. C., KRUGGEL, W. G., & BRODIE, H. J. (1973) · Endocrinology · doi:10.1210/endo-92-3-866 · Cited by 303
Aromatase Inhibitors in the Treatment and Prevention of Breast Cancer
Goss, P. E., & Strasser, K. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.881 · Cited by 298
Mechanistic studies on C-19 demethylation in oestrogen biosynthesis
Akhtar, M., Calder, M. R., Corina, D. L., & Wright, J. N. (1982) · Biochemical Journal · doi:10.1042/bj2010569 · Cited by 292
Purification and characterization of human placental aromatase cytochrome P-450.
Kellis, J. T., & Vickery, L. E. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61364-x · Cited by 290
The importance of local synthesis of estrogen within the breast
Miller, W. R., & O'Neill, J. (1987) · Steroids · doi:10.1016/0039-128x(87)90037-7 · Cited by 280
Terry, M. B. (2004) · JAMA · doi:10.1001/jama.291.20.2433 · Cited by 271
Arimidex�: A potent and selective fourth-generation aromatase inhibitor
Plourde, P. V., Dyroff, M., & Dukes, M. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00682745 · Cited by 258
Jonat, W., Howell, A., Blomqvist, C., Eiermann, W., Winblad, G., Tyrrell, C., Mauriac, L., Roche, H., Lundgren, S., Hellmund, R., et al. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00014-3 · Cited by 254
Bhatnagar, A. S., Häusler, A., Schieweck, K., Lang, M., & Bowman, R. (1990) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(90)90460-3 · Cited by 246
Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens
Brueggemeier, R. W., Quinn, A. L., Parrett, M. L., Joarder, F. S., Harris, R. E., & Robertson, F. M. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00050-6 · Cited by 238
Self-citationDowsett, M., Jones, A. L., Johnston, S. R. D., Jacobs, S., Trunet, P. F., & Smith, I. E. (1995) · PubMed · Cited by 238
The role of COX-2 inhibition in breast cancer treatment and prevention
Arun, B., & Goss, P. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.03.042 · Cited by 235
4-HYDROXYANDROSTENEDIONE IN TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER
Coombes, R. C., Dowsett, M., Goss, P., Gazet, J.-C., & Brodie, A. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92795-8 · Cited by 235
Paridaens, R., Dirix, L., Lohrisch, C., Beex, L., Nooij, M., Cameron, D., Biganzoli, L., Cufer, T., Duchateau, L., Hamilton, A., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg362 · Cited by 230
Aromatase activity in normal breast and breast tumor tissues: In vivo and in vitro studies
James, V. H. T., McNeill, J. M., Lai, L. C., Newton, C. J., Ghilchik, M. W., & Reed, M. J. (1987) · Steroids · doi:10.1016/0039-128x(83)90077-6 · Cited by 219
Goss, P. E., Powles, T., Dowsett, M., Hutchison, G., Brodie, A. M., Gazet, J. C., & Coombes, R. C. (1986) · PubMed · Cited by 215
Brodie, A. M. H., Garrett, W. M., Hendrickson, J. R., Tsai-Morris, C.-H., Marcotte, P. A., & Robinson, C. H. (1981) · Steroids · doi:10.1016/0039-128x(81)90087-8 · Cited by 215
A three‐dimensional model of aromatase cytochrome P450
Graham‐Lorence, S., Peterson, J. A., Amarneh, B., Simpson, E. R., & White, R. E. (1995) · Protein Science · doi:10.1002/pro.5560040605 · Cited by 209
Buzdar, A. U., Jones, S. E., Vogel, C. L., Wolter, J., Plourde, P., Webster, A., & for the Arimidex Study Group (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<730::aid-cncr10>3.0.co;2-0 · Cited by 207
Johannessen, D. C., Engan, T., di Salle, E., Zurlo, M. G., Paolini, J., Ornati, G., Piscitelli, G., Kvinnsland, S., & Lønning, P. E. (1997) · PubMed · Cited by 192
Studies of human placental aromatase
Siiteri, P. K., & Thompson, E. A. (1975) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(75)90149-1 · Cited by 181
Use of aromatase inhibitors in breast carcinoma.
Santen, R. J., & Harvey, H. A. (1999) · Endocrine-related cancer · doi:10.1677/erc.0.0060075 · Cited by 165
Aromatase inhibition by flavonoids
Ibrahim, A.-R., & Abul-Hajj, Y. J. (1990) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(90)90335-i · Cited by 160
Cyclooxygenase Inhibitors Suppress Aromatase Expression and Activity in Breast Cancer Cells
Díaz‐Cruz, E. S., Shapiro, C. L., & Brueggemeier, R. W. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2029 · Cited by 156
Self-citationReed, M. J., Owen, A. M., Lai, L. C., et al. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910440208 · Cited by 155
Aromatase and COX-2 expression in human breast cancers
Brodie, A. M., Lü, Q., Long, B. J., Fulton, A. M., Chen, T., Macpherson, N. A., DeJong, P. C., Blankenstein, M. A., Nortier, J. W. R., Slee, P. H. T. J., et al. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00131-5 · Cited by 150
6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): A new irreversible aromatase inhibitor
Giudici, D., Ornati, G., Briatico, G., Buzzetti, F., Lombardi, P., & di Salle, E. (1988) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(88)90129-x · Cited by 150
Evans, T. R. J., di Salle, E., Ornati, G., Lassus, M., Benedetti, M. S., Pianezzola, E., & Coombes, R. C. (1992) · PubMed · Cited by 149
Substrate-induced inactivation of aromatase by allenic and acetylenic steroids
Metcalf, B. W., Wright, C. L., Burkhart, J. P., & Johnston, J. O. (1981) · Journal of the American Chemical Society · doi:10.1021/ja00401a054 · Cited by 141
Tissue-specific promoters regulate aromatase cytochrome P450 expression
Simpson, E. R., Mahendroo, M., Means, G., Kilgore, M. W., Corbin, C. J., & Mendelson, C. R. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90235-o · Cited by 132
Aromatase and 17β-hydroxysteroid dehydrogenase inhibition by flavonoids
Bail, J.-C. L., Laroche, T., Marre-Fournier, F., & Habrioux, G. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00211-0 · Cited by 130
Recanatini, M., Bisi, A., Cavalli, A., Belluti, F., Gobbi, S., Rampa, A., Valenti, P., Palzer, M., Palusczak, A., & Hartmann, R. W. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000955s · Cited by 129
Covey, D. F., Hood, W. F., & Parikh, V. D. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69924-2 · Cited by 128
Tamoxifen: Toxicities and Drug Resistance During the Treatment and Prevention of Breast Cancer
Jordan, V. C. (1995) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.001211 · Cited by 126
Organization of the Human Aromatase P450 ( CYP19 ) Gene
Bulun, S. E., Takayama, K., Suzuki, T., Sasano, H., Yılmaz, B., & Sebastian, S. (2004) · Seminars in Reproductive Medicine · doi:10.1055/s-2004-823022 · Cited by 124
The Final Catalytic Step of Cytochrome P450 Aromatase: A Density Functional Theory Study
Hackett, J. C., Brueggemeier, R. W., & Hadad, C. M. (2005) · Journal of the American Chemical Society · doi:10.1021/ja044716w · Cited by 122
Self-citationBuzdar, A. U., & Howell, A. (2001) · PubMed · Cited by 115
Synthesis and biochemical evaluation of inhibitors of estrogen biosynthesis
Brueggemeier, R. W., Floyd, E., & Counsell, R. E. (1978) · Journal of Medicinal Chemistry · doi:10.1021/jm00208a002 · Cited by 112
Self-citationControl of aromatase activity in breast cancer cells: The role of cytokines and growth factors
Reed, M. J., Topping, L., Coldham, N. G., Purohit, A., Ghilchik, M. W., & James, V. H. T. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90264-w · Cited by 111
Chalcones are potent inhibitors of aromatase and 17β-hydroxysteroid dehydrogenase activities
Bail, J.-C. L., Pouget, C., Fagnère, C., Basly, J. P., Chulia, A.-J., & Habrioux, G. (2001) · Life Sciences · doi:10.1016/s0024-3205(00)00974-7 · Cited by 109
Regulation of Aromatase Activity Within the Breast
Miller, W. R., Mullen, P., Sourdaine, P., Watson, C. J. E., Dixon, J. M., & Telford, J. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80012-x · Cited by 105
Zhao, Y., Agarwal, V. R., Mendelson, C. R., & Simpson, E. R. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80013-1 · Cited by 105
Richards, J. A., & Brueggemeier, R. W. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021475 · Cited by 104
Self-citationAromatase Inhibitors and Breast Cancer
Brodie, A. M. H., & Njar, V. C. (1996) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-4266-6_12 · Cited by 104
Endocrine therapy in the treatment of metastatic breast cancer
Buzdar, A. U. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90122-8 · Cited by 101
Medical adrenalectomy using aminoglutethimide and dexamethasone in advanced breast cancer
Lipton, A., & Santen, R. J. (1974) · Cancer · doi:10.1002/1097-0142(197402)33:2<503::aid-cncr2820330227>3.0.co;2-l · Cited by 98
Demers, L. M. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00682744 · Cited by 95
Brodie, A., Lü, Q., & Long, B. J. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00051-5 · Cited by 90
Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer
Santen, R. J., SAMOJLIK, E., Lipton, A., Harvey, H. A., Ruby, E. B., Wells, S. A., & Kendall, J. W. (1977) · Cancer · doi:10.1002/1097-0142(197706)39:6<2948::aid-cncr2820390681>3.0.co;2-9 · Cited by 88
Binding Characteristics of Aromatase Inhibitors and Phytoestrogens to Human Aromatase
Chen, S., Kao, Y., & Laughton, C. A. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(96)00220-8 · Cited by 85
Aromatase inhibitors in the treatment of breast cancer
Brodie, A. M. H. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90269-0 · Cited by 83
BOSSCHE, H. V., Willemsens, G., Roels, I., Bellens, D., Moereels, H., Coene, M. C., Jeune, L. L., Lauwers, W., & Janssen, P. A. J. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90346-m · Cited by 81
Aromatase inhibitors ? mechanisms of steroidal inhibitors
Brueggemeier, R. W. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00682739 · Cited by 75
Self-citationMolecular pharmacology of aromatase and its regulation by endogenous and exogenous agents
Brueggemeier, R. W., Richards, J. A., Joomprabutra, S., Bhat, A., & Whetstone, J. L. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00127-3 · Cited by 74
Self-citationFirst generation aromatase inhibitors ? aminoglutethimide and testololactone
Cocconi, G. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00682741 · Cited by 73
Advances in Endocrine Treatments for Postmenopausal Women with Metastatic and Early Breast Cancer
Buzdar, A. U. (2003) · The Oncologist · doi:10.1634/theoncologist.8-4-335 · Cited by 73
Banting, L., Nicholls, P. J., Shaw, M., & Smith, H. J. (1989) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70242-x · Cited by 70
Harris, R. E., Robertson, F. M., Abou‐Issa, H., Farrar, W. B., & Brueggemeier, R. W. (1999) · Medical Hypotheses · doi:10.1054/mehy.1998.0009 · Cited by 70
Self-citationCovey, D. F., & Hood, W. F. (1982) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14590-2 · Cited by 70
Bajetta, E., Zilembo, N., Dowsett, M., Guillevin, L., Leo, A. D., Celio, L., Martinetti, A., Marchianò, A. V., Pozzi, P., Stani, S. C., et al. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00392-x · Cited by 69
Marcotte, P. A., & Robinson, C. H. (1982) · Steroids · doi:10.1016/0039-128x(82)90151-9 · Cited by 65
Lubet, R. A., Steele, V. E., Casebolt, T. L., Eto, I., Kelloff, G. J., & Grubbs, C. J. (1994) · Carcinogenesis · doi:10.1093/carcin/15.12.2775 · Cited by 62
Synthesis and Aromatase Inhibitory Activity of Flavanones
Pouget, C., Fagnère, C., Basly, J. P., Besson, A., Champavier, Y., Habrioux, G., & Chulia, A.-J. (2002) · Pharmaceutical Research · doi:10.1023/a:1014490817731 · Cited by 56
Schieweck, K., Bhatnagar, A. S., Batzl‐Hartmann, C., & LANG, M. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90270-7 · Cited by 55
Breast cancer prevention—clinical trials strategies involving aromatase inhibitors
Goss, P. E. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00378-9 · Cited by 54
Aromatase: A Target Enzyme in Breast Cancer
Johnston, J. O., & Metcalf, B. W. (1984) · Elsevier eBooks · doi:10.1016/b978-0-12-676980-7.50014-7 · Cited by 51
Control of aromatase in breast cancer cells and its importance for tumor growth
Dowsett, M., Macaulay, V. M., Gledhill, J., et al. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90266-y · Cited by 49
The minimal effective exemestane dose for endocrine activity in advanced breast cancer
Bajetta, E., Zilembo, N., Noberasco, C., et al. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00494-7 · Cited by 46
Goss, P. E., Jarman, M., Wilkinson, J. R., et al. (1986) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(86)90128-7 · Cited by 45
Validation of new aromatase monoclonal antibodies for immunohistochemistry: progress report
Sasano, H., Edwards, D. P., Anderson, T. J., Silverberg, S. G., Evans, D. B., Santen, R. J., Ramage, P., Simpson, E. R., Bhatnagar, A. S., & Miller, W. R. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00363-7 · Cited by 45
Bajetta, E., Martinetti, A., Zilembo, N., Pozzi, P., Torre, I. L., Ferrari, L., Seregni, E. C., Longarini, R., Salvucci, G., & Bombardieri, E. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf083 · Cited by 45
Yue, W., & Brodie, A. M. H. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00072-1 · Cited by 44
Structure-Activity Relationships for Non-Steroidal Inhibitors of Aromatase
Banting, L., Smith, H. J., James, M., et al. (1988) · Journal of enzyme inhibition · doi:10.3109/14756368809040728 · Cited by 38
Li, P., & Brueggemeier, R. W. (1990) · Journal of Medicinal Chemistry · doi:10.1021/jm00163a017 · Cited by 37
Self-citationCoster, R. D., Ginckel, R. V., Callens, M., Goeminne, N., & Janssens, B. L. (1992) · PubMed · Cited by 36
Comparative clinical pharmacology and pharmacokinetic interactions of aromatase inhibitors
Boeddinghaus, I., & Dowsett, M. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00126-1 · Cited by 35
Biochemical and Molecular Aspects of Aromatase
Brueggemeier, R. W. (1990) · Journal of enzyme inhibition · doi:10.3109/14756369009040731 · Cited by 31
Self-citationBrueggemeier, R. W., & Katlic, N. E. (1987) · PubMed · Cited by 30
Self-citationMechanisms of Action of Antiestrogens: Relevance to Clinical Benefits and Risks
Carmichael, P. L. (1998) · Cancer Investigation · doi:10.3109/07357909809032891 · Cited by 29
Hughes, R., Timmermans, P., & Schrey, M. P. (1996) · International Journal of Cancer · Cited by 26
Clinical Use of Aromatase Inhibitors in the Treatment of Advanced Breast Cancer
Trunet, P. F., Vreeland, F., Royce, C., Chaudri, H. A., Cooper, J., & Bhatnagar, A. S. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80018-0 · Cited by 21
Gartner, C. A., Thompson, S. J., Rettie, A. E., & Nelson, S. D. (2001) · Protein Expression and Purification · doi:10.1006/prep.2001.1464 · Cited by 18
Nonsteroidal and steroidal aromatase inhibitors in breast cancer.
Hamilton, A. L., & Volm, M. (2001) · PubMed · Cited by 18
A-ring bridged steroids as potent inhibitors of aromatase
Peet, N. P., Johnston, J. O., Burkhart, J. P., & Wright, C. L. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90244-q · Cited by 15
O'Reilly, J. M., & Brueggemeier, R. W. (1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(96)00087-8 · Cited by 14
Self-citationBrodie, A., & Mouridsen, H. T. (2003) · American Journal of Clinical Oncology · doi:10.1097/00000421-200308001-00004 · Cited by 14
Comparison of In Vitro Exemestane Activity Versus Other Antiaromatase Agents
Soudon, J. (2000) · Clinical Breast Cancer · doi:10.3816/cbc.2000.s.013 · Cited by 11
Current status of adjuvant endocrine therapy for breast cancer.
Ingle, J. N. (2001) · PubMed · Cited by 9
Cited by
Chromone: A Valid Scaffold in Medicinal Chemistry
Gaspar, A., Matos, M. J., Garrido, J., Uriarte, E., & Borges, F. (2014) · Chemical Reviews · doi:10.1021/cr400265z · Cited by 760
Breast Cancer Treatments: Updates and New Challenges
Burguin, A., Diorio, C., & Durocher, F. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080808 · Cited by 488
Cowey, S., & Hardy, R. W. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.051090 · Cited by 431
Cheshenko, K., Pakdel, F., Segner, H., Kah, O., & Eggen, R. I. L. (2008) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2007.03.005 · Cited by 334
Han, S., Choi, K., Kim, J., Ji, K., Kim, S., Ahn, B., Yun, J., Choi, K., Khim, J. S., Zhang, X., et al. (2010) · Aquatic Toxicology · doi:10.1016/j.aquatox.2010.02.013 · Cited by 332
Metadata
- Authors
- Brueggemeier, R. W., Hackett, J. C., & Diaz-Cruz, E. S.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2005-04-06
- Volume
- 26
- Issue
- 3
- Pages
- 331-345
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2144896165
- Cited by
- 484
- References
- 119
- FWCI
- 15.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.